 |
InterPro: IPR015341 Glycoside hydrolase, family 38, central domain
Publications
|
|
1.
|
Heikinheimo P, Helland R, Leiros HK, Leiros I, Karlsen S, Evjen G, Ravelli R, Schoehn G, Ruigrok R, Tollersrud OK, McSweeney S, Hough E.
The structure of bovine lysosomal alpha-mannosidase suggests a novel mechanism for low-pH activation.
J. Mol. Biol. 327 631-44 2003
[PubMed: 12634058]
http://dx.doi.org/10.1016/S0022-2836(03)00172-4
|
Additional Reading
|
|
Kuntz DA, Tarling CA, Withers SG, Rose DR.
Structural analysis of Golgi alpha-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen.
Biochemistry 47 2008 10058-68
[PubMed: 18759458]
http://dx.doi.org/10.1021/bi8010785
|
|
Zhong W, Kuntz DA, Ember B, Singh H, Moremen KW, Rose DR, Boons GJ.
Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant.
J. Am. Chem. Soc. 130 2008 8975-83
[PubMed: 18558690]
http://dx.doi.org/10.1021/ja711248y
|
|
Kumar NS, Kuntz DA, Wen X, Pinto BM, Rose DR.
Binding of sulfonium-ion analogues of di-epi-swainsonine and 8-epi-lentiginosine to Drosophila Golgi alpha-mannosidase II: the role of water in inhibitor binding.
Proteins 71 2008 1484-96
[PubMed: 18076078]
http://dx.doi.org/10.1002/prot.21850
|
|
Shah N, Kuntz DA, Rose DR.
Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site.
Proc. Natl. Acad. Sci. U.S.A. 105 2008 9570-5
[PubMed: 18599462]
http://dx.doi.org/10.1073/pnas.0802206105
|
|
Fiaux H, Kuntz DA, Hoffman D, Janzer RC, Gerber-Lemaire S, Rose DR, Juillerat-Jeanneret L.
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site.
Bioorg. Med. Chem. 16 2008 7337-46
[PubMed: 18599296]
http://dx.doi.org/10.1016/j.bmc.2008.06.021
|
|
|
InterPro 23.1
|